David Goldstein

14PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples life courseCancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 21, 2026
HSP47 is a potential dual cell target and prognostic factor in pancreatic cancer.

|Apr 23, 2026
Impact of Spiritual Wellbeing in Advanced Cancer Patients Receiving Genomic Test Results.

|Jun 16, 2025
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.

Michael Michael, Rachel Wong, Sanjeev Gill

|Apr 08, 2025
Navigating pain and appetite challenges in palliative care for pancreatic cancer: insights from a national, longitudinal consecutive cohort study.

Mariana S Sousa, Maja Villanueva Garcia, Megan Blanchard

|Mar 29, 2023
Irradiation-Induced Dysbiosis: The Compounding Effect of High-Fat Diet on Metabolic and Immune Functions in Mice.

Briana K Clifford, Nadia M L Amorim, Nadeem O Kaakoush

|Jul 09, 2022
Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study.

Megan C Best, Nicci Bartley, Christine E Napier

Pageof 3

Frequent Collaborators

6 joint publications

Megan C Best

6 joint publications

Mandy L Ballinger

6 joint publications

David Thomas

6 joint publications

Phyllis Butow